Ameriprise’s MaxLinear MXL Stock Holding History

Ameriprise’s Portfolio MXL Stock Details MXL Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q3	–	Sell	-8,700	Closed	-$275K	–	3938
2023 Q2	$275K	Buy	+8,700	New	+$251K	﹤0.01%	3633

Other funds holding MXL

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return

Jane Street New York $1.21T AUM 78.12% 1-Year Est. Return

D.E. Shaw & Co New York $210B AUM 57.28% 1-Year Est. Return

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Ameriprise's MXL Position: Q2 2026 in Review

Ameriprise reduced its MaxLinear (MXL) stake by 46% in Q2 2026, selling an estimated $18M and leaving 302,536 shares worth $38.8M. The position accounts for 0.01% of the portfolio, ranked #1078.

Ameriprise first reported a position in MXL in Q2 2013 and has held it in 51 quarters since. The position peaked at $62M in Q4 2021. 433 funds tracked by Wall St. Rank hold MXL as of Q2 2026.

Ameriprise held 302,536 shares of MaxLinear worth $38.8M as of Q2 2026.
Ameriprise sold 254,984 MaxLinear shares in Q2 2026, an estimated $18M.
MaxLinear made up 0.01% of Ameriprise's portfolio in Q2 2026, its #1078 holding.
Ameriprise first reported a position in MaxLinear in Q2 2013 and has held it in 51 quarters since.
Ameriprise's MaxLinear position peaked at $62M in Q4 2021.
433 funds tracked by Wall St. Rank held MaxLinear as of Q2 2026.

Based on Ameriprise's 13F filing for Q2 2026, filed 14 Aug 2026.